These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 33130510)
1. Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test. Xie X; Nielsen MC; Muruato AE; Fontes-Garfias CR; Ren P Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115248. PubMed ID: 33130510 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test. Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695 [TBL] [Abstract][Full Text] [Related]
3. Development, performance evaluation, and clinical application of a Rapid SARS-CoV-2 IgM and IgG Test Kit based on automated fluorescence immunoassay. Kang K; Huang L; Ouyang C; Du J; Yang B; Chi Y; He S; Ying L; Chen G; Wang J J Med Virol; 2021 May; 93(5):2838-2847. PubMed ID: 33231312 [TBL] [Abstract][Full Text] [Related]
4. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917 [TBL] [Abstract][Full Text] [Related]
5. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting. Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Valcourt EJ; Manguiat K; Robinson A; Chen JC; Dimitrova K; Philipson C; Lamoureux L; McLachlan E; Schiffman Z; Drebot MA; Wood H Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115294. PubMed ID: 33387896 [TBL] [Abstract][Full Text] [Related]
7. Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test. Kulkarni R; Shrivastava S; Patil HP; Kore P; Rane P; Palkar S; Lalwani S; Mishra AC; Arankalle VA Indian J Med Res; 2021 May; 153(5&6):658-664. PubMed ID: 34145085 [TBL] [Abstract][Full Text] [Related]
8. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation. Jääskeläinen AJ; Kuivanen S; Kekäläinen E; Ahava MJ; Loginov R; Kallio-Kokko H; Vapalahti O; Jarva H; Kurkela S; Lappalainen M J Clin Virol; 2020 Aug; 129():104512. PubMed ID: 32563180 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings. Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999 [TBL] [Abstract][Full Text] [Related]
10. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response. David A; Scott L; Jugwanth S; Gededzha M; Kahamba T; Zwane N; Mampeule N; Sanne I; Stevens W; Mayne ES J Immunol Methods; 2021 Sep; 496():113096. PubMed ID: 34242653 [TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott). Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222 [TBL] [Abstract][Full Text] [Related]